(Total Views: 83)
Posted On: 04/26/2021 2:45:53 PM
Post# of 25131
$PIRS News Article - Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific https://marketwirenews.com/news-releases/pier...46236.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
